VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 144 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,331,000 | +29.3% | 69,046 | +70.9% | 0.12% | +27.1% |
Q2 2022 | $1,029,000 | +37.2% | 40,398 | +38.6% | 0.10% | +52.4% |
Q1 2022 | $750,000 | -29.7% | 29,157 | +14.4% | 0.06% | -30.0% |
Q4 2021 | $1,067,000 | +101.3% | 25,487 | +109.2% | 0.09% | +73.1% |
Q3 2021 | $530,000 | -17.3% | 12,184 | -10.1% | 0.05% | -21.2% |
Q2 2021 | $641,000 | +25.2% | 13,551 | +35.8% | 0.07% | +8.2% |
Q1 2021 | $512,000 | -33.7% | 9,982 | -65.4% | 0.06% | -33.7% |
Q4 2020 | $772,000 | – | 28,814 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |